EBM — Eastwood Bio-Medical Canada Share Price
0.000.00%
Last trade - 00:00- CA$47.53m
- CA$47.58m
- CA$0.87m
- 39
- 24
- 21
- 18
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 64.51 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -72.18% | ||
Financial Summary
| Year End 31st Oct | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 1.29 | 0.72 | 0.98 | 1.3 | 0.87 | n/a | n/a | 3.13% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Eastwood Bio-Medical Canada Inc. is engaged in marketing and distributing natural health products in North America. It is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients that are presented in tea or capsule forms. The Eleotin products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. Its licensed products include Eleotin A 700, which is a treatment for spleen deficiency, lack of appetite and fatigue; Eleotin AL88, a laxative; Eleotin Cal20, for bone and teeth maintenance; Eleotin V3D, for the development and maintenance of bones, teeth and good health; Eleotin G2000, for cardiovascular health; Eleotin H55, for sedative and tension relief, and Eleotin Zn330, for the tissue formation and metabolism. In addition, it offers Eleotin Bentley to promote healthy glucose levels and Eleotin LBM for hypertension relief.
Directors
- Last Annual
- October 31st, 2023
- Last Interim
- January 31st, 2024
- Incorporated
- December 10th, 2010
- Public Since
- September 5th, 2014
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 68,885,969
- Address
- 1130 - 4871 Shell Road, RICHMOND, V6X 3Z6
- Web
- https://eleotin.ca/
- Phone
- +1 6042472100
- Auditors
- Saturna Group Chartered Professional Accountants LLP
Upcoming Events for EBM
Eastwood Bio-Medical Canada Inc Annual Shareholders Meeting
Q3 2024 Eastwood Bio-Medical Canada Inc Earnings Release
Similar to EBM
Aequus Pharmaceuticals
TSX Venture Exchange
Avricore Health
TSX Venture Exchange
Biosyent
TSX Venture Exchange
Cytophage Technologies
TSX Venture Exchange
Decibel Cannabis
TSX Venture Exchange
FAQ
What is the Eastwood Bio-Medical Canada share price?
As of Today at 19:07 UTC, shares in Eastwood Bio-Medical Canada are trading at CA$0.69. This share price information is delayed by 15 minutes.
How has the Eastwood Bio-Medical Canada share price performed this year?
Shares in Eastwood Bio-Medical Canada last closed at CA$0.69 and the price had moved by -8% over the past 365 days. In terms of relative price strength the Eastwood Bio-Medical Canada share price has underperformed the Toronto Stock Exchange 300 Composite Index by -12.7% over the past year.
What are the analyst and broker recommendations for Eastwood Bio-Medical Canada?
There is no consensus recommendation for this security.
What is the Eastwood Bio-Medical Canada dividend yield?
Eastwood Bio-Medical Canada does not currently pay a dividend.
Does Eastwood Bio-Medical Canada pay a dividend?
Eastwood Bio-Medical Canada does not currently pay a dividend.
When does Eastwood Bio-Medical Canada next pay dividends?
Eastwood Bio-Medical Canada does not currently pay a dividend.
How do I buy Eastwood Bio-Medical Canada shares?
To buy shares in Eastwood Bio-Medical Canada you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Eastwood Bio-Medical Canada?
As of the previous close price of CA$0.69, shares in Eastwood Bio-Medical Canada had a market capitalisation of CA$47.53m.
Where are Eastwood Bio-Medical Canada shares listed?
Here are the trading details for Eastwood Bio-Medical Canada:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: EBM
What kind of share is Eastwood Bio-Medical Canada?
Based on an overall assessment of its quality, value and momentum Eastwood Bio-Medical Canada is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Eastwood Bio-Medical Canada share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Eastwood Bio-Medical Canada share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eastwood Bio-Medical Canada. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -11.37%.
As of the last closing price of CA$0.69, shares in Eastwood Bio-Medical Canada were trading -32.2% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Eastwood Bio-Medical Canada PE Ratio?
The Eastwood Bio-Medical Canada PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.69.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Eastwood Bio-Medical Canada?
Eastwood Bio-Medical Canada's management team is headed by:
- Yunji Kim - PRE
- Youngsoo Kim - CEO
- Marcus Kuypers - IND
- Ian Mallmann - IND
- Terrance Owen - IND